Prevalence of human papilloma virus infection in pregnant Turkish women compared with non-pregnant women

European Journal of Gynaecological Oncology

Volumn 31, Issue 1, 2010, Pages 72-74

  Aydin, Y ^a   Atis, A ^b   Tutuman, T ^b   Goker, N ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Cervical cancer; Genotyping; Human papillomavirus; Prevalence; Turkish women

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GENOTYPE; HUMAN; HUMAN TISSUE; INFECTION RATE; MAJOR CLINICAL STUDY; NONHUMAN; ONCOGENE; PREGNANT WOMAN; PREVALENCE; TUMOR VIRUS; TURKEY (REPUBLIC); VIRUS GENE; VIRUS INFECTION; WART VIRUS;

ADULT; FEMALE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; TURKEY;

EID: 77349103870     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Pisani P., Bray F., Parkin D.M.: "Estimates of the world-wide prevalence of cancer for 25 sites in the adult population". Int. J. Cancer, 2002, 97, 72.
2. Pisani P., Parkin D.M., Bray F., Ferlay J.: "Estimates of the worldwide mortality from 25 cancers in 1990". Int. J. Cancer, 1999, 83, 18.
3. Iihara K., Shiozaki H., Tahara H., Kobayashi K., Inoue M., Tamura S. et al.: "Prognostic significance of transforming growth factor-alpha in human esophageal carcinoma: Implication for the autocrine proliferation". Cancer, 1993, 71, 2902.
4. Parkin D.M., Bray F., Ferlay J., Pisani P.: "Global cancer statistics, 2002". CA Cancer J. Clin., 2005, 55, 74.
5. Castle P.E., Hillier S.L., Rabe L.K., Hildesheim A., Herrero R., Bratti M.C. et al.: "An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV)". Cancer Epidemiol. Biomark. Prev., 2001, 10, 1021.
6. Clifford G.M., Gallus S., Herrero R., Munoz N., Snijders P.J., Vaccarella S. et al.: "Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis". Lancet, 2005, 366, 991.
7. Richardson H., Franco E., Pintos J., Bergeron J., Arella M., Teuer P.: "Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal University students". Sex. Transm. Dis., 2000, 27, 79.
8. Franco E. (ed.): "Epidemiology of anogenital warts and cancer. Obstetrics and Gynecology Clinics of North America: Human Papillomavirus I". 1996, Philadelphia, W. B. Saunders.
9. ZurHausen H., deVilliers E.M. (eds): "Human papillomavirus". Annu. Rev. Microbiol., 1994, 48, 427.
10. Bosch F.X.: "The rolling dossier of cervical cancer prevention". HPV Today (August 9, 2006), 2.
11. Meijer C.J., Snijders P.J., Castle P.E.: "Clinical utility of HPV genotyping". Gynecol. Oncol., 2006, 103, 12.
12. Apgar B.S., Zoschnick L., Wright T.C. Jr.: "The 2001 Bethesda System terminology". Am. Fam. Phys., 2003, 68, 1992.
13. De-Roda H.A., Walboomers J.M., Van-den B.A., Meijer C.J., Snijders P.J.: "The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR". J. Gen. Virol., 1995, 76, 1057.
14. Sotlar K., Diemer D., Dethleffs A., Hack Y., Stubner A., Vollmer N. et al.: "Detection and typing of human papillomavirus by e6 nested multiplex PCR". J. Clin. Microbiol., 2004 , 42, 3176.
15. Bell M., Schmidt G.D., Patrick S., Ryschon T., Linz L., Chauhan C.S.: "There is a high prevalence of human papillomavirus infection in American Indian women of the Northern Plains". Gynecol. Oncol., 2007, 107, 236.
16. Li Y., Wang Y., Jia C., Ma Y., Lan Y., Wang S.: "Detection of human papilloma virus genotypes with liquid bead microarray in cervical lesions of Northen Chinese patients". Cancer Genetic and Cytogenetics, 2008, 182, 12.
17. Clifford G.M., Gallus S., Herrero R., Munoz N., Snijders P.J., Vaccarella S. et al.: "Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis". Lancet, 2005, 366, 991.
18. Stockman P. C., Segard C., Bennamar S., Gondry J., Boulanger J. C., Sevestre H. et al.: "Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities". J. Clin. Virol., 2008, 42, 353.
19. Hrushesky W.J., Sothern R.B., Rietveld W.J., Du Quiton J., Boon M.E.: "Season, sun, sex, and cervical cancer". Cancer Epidemiol. Biomark. Prev., 2005, 14, 1940.
20. Hrushesky W.J., Sothern R.B., Rietveld W.J., Du-Quiton J., Boon M.E.: "Sun exposure, sexual behavior and uterine cervical human papilloma virus". Int. J. Biometeorol., 2006, 50, 167.
21. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Ault K.A, Giuliano A.R. et al.: "Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial". Lancet Oncol., 2005, 6, 271.
22. Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., Romanowski B., Roteli-Martins C.M. et al.: "Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial". Lancet, 2006, 367, 1247.
23. Koutsky L.A., Harper D.M.: "Chapter 13: current findings from prophylactic HPV vaccine trials". Vaccine, 2006, 24 (suppl. 3), S121. Koutsky L.A. and Harper D.M.: "Chapter 13: current findings from prophylactic HPV vaccine trials". Vaccine, 2006, 24 (suppl. 3), S121.